>
GURUFOCUS.COM > STOCK LIST > Healthcare > Drug Manufacturers > Bristol-Myers Squibb Co (NYSE:BMY) > Definitions > Profitability Rank
Switch to:

Bristol-Myers Squibb Co Profitability Rank

: 8 (As of Mar. 2022)
View and export this data going back to 1952. Start your Free Trial

Bristol-Myers Squibb Co has the Profitability Rank of 8. It has a higher profitability and may stay that way.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Bristol-Myers Squibb Co's Operating Margin % for the quarter that ended in Mar. 2022 was 22.91%. As of today, Bristol-Myers Squibb Co's Piotroski F-Score is 8.


Competitive Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Bristol-Myers Squibb Co Profitability Rank Distribution

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Profitability Rank falls into.



Bristol-Myers Squibb Co Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Bristol-Myers Squibb Co has the Profitability Rank of 8. It has a higher profitability and may stay that way.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Bristol-Myers Squibb Co's Operating Margin % for the quarter that ended in Mar. 2022 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2022 ) / Revenue (Q: Mar. 2022 )
=2669 / 11648
=22.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Good Sign:

Piotroski F-Score is 8, indicating very healthy situation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Bristol-Myers Squibb Co has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

Warning Sign:

Bristol-Myers Squibb Co operating margin has been in 5-year decline. The average rate of decline per year is -14.2%.

4. Consistency of the profitability

5. Predictability Rank


Bristol-Myers Squibb Co Profitability Rank Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co Business Description

Bristol-Myers Squibb Co logo
Industry
Healthcare » Drug Manufacturers NAICS : 325412 SIC : 2834
Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Executives
Vousden Karen H director 345 PARK AVENUE NEW YORK NY 10154
Samuels Theodore R. Ii director 1990 E. GRAND AVE. EL SEGUNDO CA 90245
Haller Julia A director C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Paliwal Dinesh C director 5454 W 110TH STREET OVERLAND PARK KS 66211
Rice Derica W director LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Emmens Matthew director C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST., ATTN: GENERAL COUNSEL CAMBRIDGE MA 02139
Bertolini Robert J director C/O SCHERING PLOUGH CORP 2000 GALLOPING HILL RD KENILWORTH NJ 070333
Price Paula A director ONE CVS DRIVE WOONSOCKET RI 02895
Yale Phyllis R director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: YALE PHYLLIS R a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Bonney Michael W director 65 HAYDEN AVE LEXINGTON MA 02421
Arduini Peter J director 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536
Santiago Karen Murphy officer: SVP & Controller BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCE LINE ROAD PRINCETON NJ 08540
Caforio Giovanni director, officer: Chairman and CEO BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCELINE ROAD LAWRENCEVILLE NJ 08543
Eid Joseph officer: SVP,Head Glob. Medical Affairs BRISTOL-MYERS SQUIBB COMPANY 3401 PRINCETON PIKE LAWRENCEVILLE NJ 08648
Leung Sandra officer: EVP, General Counsel C/O BRISTOL MYERS SQUIBB CO 345 PARK AVE NEW YORK NY 10164

Bristol-Myers Squibb Co Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)